LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK)
HKD 24.1
(4.78%)
HKD 24.1
(4.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 189.2 Million CNY | 521.84% |
| 2022 | 18.8 Million CNY | -66.07% |
| 2021 | 87.37 Million CNY | 5.54% |
| 2020 | 82.8 Million CNY | 32.26% |
| 2019 | 62.21 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 154.81 Million CNY | 67.53% |
| 2023 FY | - CNY | 521.84% |
| 2023 Q4 | 92.4 Million CNY | 8.14% |
| 2023 Q2 | 85.45 Million CNY | 54.15% |
| 2022 Q2 | 62.55 Million CNY | 67.4% |
| 2022 FY | - CNY | -66.07% |
| 2022 Q4 | 55.43 Million CNY | -11.38% |
| 2021 FY | - CNY | 5.54% |
| 2021 Q4 | 37.36 Million CNY | -43.82% |
| 2021 Q2 | 66.51 Million CNY | 0.0% |
| 2020 FY | - CNY | 32.26% |
| 2019 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|